These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32262822)

  • 1. An overview of nanotoxicity and nanomedicine research: principles, progress and implications for cancer therapy.
    Wang Y; Santos A; Evdokiou A; Losic D
    J Mater Chem B; 2015 Sep; 3(36):7153-7172. PubMed ID: 32262822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Safe-by-Design Strategy towards Safer Nanomaterials in Nanomedicines.
    Yan L; Zhao F; Wang J; Zu Y; Gu Z; Zhao Y
    Adv Mater; 2019 Nov; 31(45):e1805391. PubMed ID: 30701603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic in vitro nanotoxicity study on anodic alumina nanotubes with engineered aspect ratio: understanding nanotoxicity by a nanomaterial model.
    Wang Y; Kaur G; Zysk A; Liapis V; Hay S; Santos A; Losic D; Evdokiou A
    Biomaterials; 2015 Apr; 46():117-30. PubMed ID: 25678121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles toxicity: an overview of its mechanism and plausible mitigation strategies.
    Sharma N; Kurmi BD; Singh D; Mehan S; Khanna K; Karwasra R; Kumar S; Chaudhary A; Jakhmola V; Sharma A; Singh SK; Dua K; Kakkar D
    J Drug Target; 2024 Jun; 32(5):457-469. PubMed ID: 38328920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Toxicity Implications of Multifunctional Drug Delivery Nanocarriers on Reproductive Systems
    Ahmad A
    Front Toxicol; 2022; 4():895667. PubMed ID: 35785262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced methodologies to formulate nanotheragnostic agents for combined drug delivery and imaging.
    Arias JL
    Expert Opin Drug Deliv; 2011 Dec; 8(12):1589-608. PubMed ID: 22097904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A special issue on reviews in nanomedicine, drug delivery and vaccine development.
    Nalwa HS
    J Biomed Nanotechnol; 2014 Sep; 10(9):1635-40. PubMed ID: 25992435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational approaches to cell-nanomaterial interactions: keeping balance between therapeutic efficiency and cytotoxicity.
    Ding HM; Ma YQ
    Nanoscale Horiz; 2018 Jan; 3(1):6-27. PubMed ID: 32254106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging advances in cancer nanotheranostics with graphene nanocomposites: opportunities and challenges.
    Rahman M; Akhter S; Ahmad MZ; Ahmad J; Addo RT; Ahmad FJ; Pichon C
    Nanomedicine (Lond); 2015; 10(15):2405-22. PubMed ID: 26252175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge gaps between nanotoxicological research and nanomaterial safety.
    Hu X; Li D; Gao Y; Mu L; Zhou Q
    Environ Int; 2016 Sep; 94():8-23. PubMed ID: 27203780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of protein-nanomaterial interaction for advanced drug delivery.
    Peng Q; Mu H
    J Control Release; 2016 Mar; 225():121-32. PubMed ID: 26812004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomaterial-Based Drug Delivery Systems for Ischemic Stroke.
    Jiang C; Zhou Y; Chen R; Yang M; Zhou H; Tang Z; Shi H; Qin D
    Pharmaceutics; 2023 Nov; 15(12):. PubMed ID: 38140010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotoxicity in Systemic Circulation and Wound Healing.
    Bakshi MS
    Chem Res Toxicol; 2017 Jun; 30(6):1253-1274. PubMed ID: 28478677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine for Cancer Therapy Using Autophagy: An Overview.
    Kotcherlakota R; Rahaman ST; Patra CR
    Curr Top Med Chem; 2018; 18(30):2599-2613. PubMed ID: 30582477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding Nanoparticle Toxicity to Direct a Safe-by-Design Approach in Cancer Nanomedicine.
    Damasco JA; Ravi S; Perez JD; Hagaman DE; Melancon MP
    Nanomaterials (Basel); 2020 Nov; 10(11):. PubMed ID: 33147800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology Inspired Advanced Engineering Fundamentals for Optimizing Drug Delivery.
    Kassem AA
    Curr Drug Targets; 2018; 19(15):1839-1854. PubMed ID: 29412103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Combo" nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy.
    Kemp JA; Shim MS; Heo CY; Kwon YJ
    Adv Drug Deliv Rev; 2016 Mar; 98():3-18. PubMed ID: 26546465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.